Boeing stock dipped slightly last week but remains the best performing DJIA index stock for the year to date. With the Dubai Air Show beginning tomorrow, the company is cautiously optimistic about getting more…
As new GE (NYSE: GE) CEO John Flannery slashes jobs, eliminates use of company aircraft and executive cars, and readies answers to what his future plans are, a large amount of the focus for…
Shares of GE regained a little ground last week, but it remains mired in its place as the worst performing stock on the DJIA index. Can CEO John Flannery's Monday presentation begin a turnaround?
Large retailers have shown such poor results that even minor progress makes it appear they have a brighter future than the one predicted for the last year. Results from several companies, most notably Macy’s…
Medical errors and suboptimal hospital conditions are a leading cause of death in the United States, resulting in hundreds of thousands of fatalities each year. Of course, some hospitals are worse than others, and…
Friday was a relatively flat day for the U.S. broad markets to close out a down week. Crude oil started off flat but pushed lower as the day went on. The S&P 500 sectors…
AES Corp., Pandora, Real Industry, and Johnson Controls all posted new 52-week lows on Friday.
Intel, Merck, McDonald's, and Exxon Mobil weighed on the DJIA Friday.
The U.S. land-based oil rig count rose by nine this week after steady declines. Oklahoma saw six rigs added in the state and New Mexico added four to its portion of the Permian basin.
More Americans are watching their favorite TV shows online than on a traditional TV. That's a big jump year over year.
We are still two weeks away from Thanksgiving, when we give thanks for the bounty that nature has provided us. But before that holiday, on Veterans Day, the nation will give thanks and show…
A proposed rule that requires light vehicles be equipped with vehicle-to-vehicle communications technology has been languishing since the Trump administration took office.
While the tech sector has been rallying NVIDIA has been at the forefront, leading the way. And it seems that the firm has done it again with a spectacular earnings report.
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Thanks to progress made in 2017 though, it looks like 2018 could see both a radically new way of delivering antibiotics and finally the first new class approved in 30 years. Here are three…
